Trapped! Flow studies reveal Thrombosis target

At Cellix, we take our hats off to our academic colleagues who are creating experimental methodologies that drive learning and new discoveries.   Thrombosis has always been a key application of our VenaFlux Solutions and this year has been no exception.  With COVID-19 at the centre of our lives, the link between COVID-19 and thrombosis has also been at the centre of our customers' research.

 But thrombosis has been affecting lives long before COVID-19. So today, as part of World Thrombosis Day, we asked the Cellix team to select one recent paper that encompasses clever design, innovative use of microfluidics and which, in their opinion, was particularly significant for thrombosis research and potential new treatments.